IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

NLS Pharmaceutics LTD

Q2 2025 vs Q3 2025

Comparing institutional holders between quarters

Quarters

Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
BVF Inc
UNCHANGED
Shares143,676 from 143,676
Change0 (0%)
Value$262.9K (-$153.7K)
Filed 2025-11-14
UBS Group AG
DECREASED
Shares38 from 14,982
Change-14,944 (-100%)
Value$70 (-$43.4K)
Filed 2025-11-13
Morgan Stanley
CLOSED
Shares0 from 2,510
Change-2,510 (-100%)
Value$0 (-$7.3K)
Filed 2026-05-27
Proequities, Inc.
N/A
Shares— from 0
Change0
Value—
Status
BVF Inc
UNCHANGED143,676143,67600%$416.7K$262.9K-$153.7K2025-11-14
UBS Group AG
DECREASED3814,982-14,944-100%$43.4K$70-$43.4K2025-11-13
Morgan Stanley
CLOSED02,510-2,510-100%$7.3K$0-$7.3K2026-05-27
Proequities, Inc.
N/A—00—$0———
Showing 4 of 4 institutions